Product Images Keppra XR
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Keppra XR NDC 50474-598 by Ucb, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - keppraxr 01
Figure 1 - keppraxr 02
This appears to be a table or chart showing percentages of patients receiving different doses of a medication (Keppra) and a placebo. The percentages are broken down into various categories, but without additional context it is unclear what those categories represent.*
Figure 2 - keppraxr 03
The text seems to be an excerpt from a clinical study report, but it lacks context and information to provide a meaningful description. It mentions some percentages related to patients and treatment with a medication called KEPPRA, as well as a placebo group. However, without knowing the purpose of the study, the criteria for patient selection, the outcomes measured, and other relevant details, it is not possible to provide a useful description of the text.*
Figure 3 - keppraxr 04
This is a table containing the percentage of patients and the number of patients (N) in a study comparing placebo and immediate-release Keppra at a dosage of 3000 mg/day. However, without additional context or information, it is difficult to determine what is being studied or what the percentages represent.*
Figure 4 - keppraxr 05
PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Label - keppraxr 06
Keppra XR is a trademark of UCBS.A. or its affiliates. The drug is manufactured for UCB, Inc. in Smyrna, GA, with PT# 4001562 and NDC 50474-598-66, 60 tablets for once daily dosing. The tablets are 500mg and are extended-release. Each patient must be given the accompanying medication guide. Dispense in a tight, light-resistant container with a child-resistant closure, and see the package insert for complete dosage recommendations. Store at 25°C (77°F), but excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature].*
PRINCIPAL DISPLAY PANEL - 750 mg Tablet Bottle Label - keppraxr 07
KEPPRA XR is a medication used for seizures, it is available in the form of extended-release tablets in doses of 750 mg. The medication comes in a bottle containing 60 tablets, NDC code 50474-599-66. The recommended dosage for KEPPRA varies and should be consulted in the package insert for complete dosage recommendations. It should be dispensed in a tight, light-resistant container with a child-resistant closure. KEPPRA XR must be prescribed by a healthcare professional and should not be taken without their advice.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.